Back to News
Market Impact: 0.1

UNCY URGENT DEADLINE: Unicycive Therapeutics, Inc. Investors Have Until November 2nd to Contact Bragar Eagel & Squire, P.C. Seeking Lead Plaintiff Role

Source: globenewswire.com

Legal & Litigation

Bragar Eagel & Squire litigation partner Brandon Walker invited Unicycive (UNCY) investors who suffered losses to contact him to discuss their options. The headline provides no details about the alleged matter, loss amounts, or any legal action or company response.

AllMind Terminal

AI-powered research, real-time alerts, and portfolio analytics for institutional investors.

Request Trial

Market Sentiment

Overall Sentiment

neutral

Sentiment Score

-0.10

More News

From AllMind Research

Browse all research